Search Within

William K Kelly

Formats
  1. Journal Article (82)
  2. Meeting Abstract (25)
  3. Book Section (6)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (82)
  3. Genitourinary Oncology Service (81)
  4. Hematologic Malignancies, Division of (34)
  5. Nursing (31)
  6. GSK Faculty (24)

More Groups

People
  1. Howard Scher (76)
  2. Susan Slovin (31)
  3. Michael Morris (24)
  4. Tracy Smart-Curley (23)
  5. Lawrence Schwartz (20)
  6. Paul Marks (16)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2009 (2)
  4. 2007 (4)
  5. 2006 (4)
  6. 2005 (21)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Clinical Cancer Research (13)
  3. Urology (13)
  4. Cancer (9)
  5. Journal of Urology (5)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Science, Inc. (20)
  3. American Association for Cancer Research (16)
  4. Elsevier Inc. (9)
  5. Wiley Blackwell (9)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (115)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus doxorubicin in the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Slovin, S. F.; Kelly, W. K.; Wilton, A.; Kattan, M.; Myskowski, P.; Mendelsohn, J.; Scher, H. I.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
    Journal Article

    Morris, M. J.; Huang, D.; Kelly, W. K.; Slovin, S. F.; Stephenson, R. D.; Eicher, C.; Delacruz, A.; Curley, T.; Schwartz, L. H.; Scher, H. I.
    European Urology (2009)

    Fulltext@MSK | Save
  • The Prostate Cancer Clinical Trials Working Group (PCCTWG) consensus criteria for phase II clinical trials for castration-resistant prostate cancer
    Meeting Abstract

    Scher, H. I.; Halabi, S.; Tannock, I.; Morris, M.; Higano, C.; Kelly, W.; Sternberg, C.; Eisenberger, M.; Martin, A.; Hussain, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
    Journal Article

    Solit, D. B.; Ivy, S. P.; Kopil, C.; Sikorski, R.; Morris, M. J.; Slovin, S. F.; Kelly, W. K.; Delacruz, A.; Curley, T.; Heller, G.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients: Randomized phase 2 study of ixabepilone or mitoxantrone and prednisone
    Journal Article

    Rosenberg, J. E.; Weinberg, V. K.; Kelly, W. K.; Michaelson, D.; Hussain, M. H.; Wilding, G.; Gross, M.; Hutcheon, D.; Small, E. J.
    Cancer (2007)

    Fulltext@MSK | Save
  • A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Kelly, W. K.; Slovin, S.; Ryan, C.; Eicher, C.; Heller, G.; Scher, H. I.
    Journal of Urology (2007)

    Fulltext@MSK | Save
  • A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: Second-line taxane-based therapy after first-line epothilone-B analog ixahepilone (BMS-247550) therapy
    Journal Article

    Rosenberg, J. E.; Galsky, M. D.; Rohs, N. C.; Weinberg, V. K.; Oh, W. K.; Kelly, W. K.; Small, E. J.
    Cancer (2006)

    Fulltext@MSK | Save
  • Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
    Journal Article

    O'Connor, O. A.; Heaney, M. L.; Schwartz, L.; Richardson, S.; Willim, R.; Macgregor-Cortelli, B.; Curly, T.; Moskowitz, C.; Portlock, C.; Horwitz, S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save